Interferon-β in Multiple Sclerosis Can We Control its Costs?

• 1 March 1997
• journal article
• Published by Springer Nature in PharmacoEconomics
• Vol. 11  (3) , 210-215
• https://doi.org/10.2165/00019053-199711030-00002

Abstract

Keywords

• EFFICACY
• COST
• MULTIPLE SCLEROSIS
• SANCTIONED
• OWING
• INTERFERON Β
• ACTIVELY PROMOTED